Jeil Pharma Holdings Inc (KRX:002620)
South Korea
· Delayed Price · Currency is KRW 7,350.00
+100.00 (1.38%)
Feb 20, 2025, 9:00 AM KST
Jeil Pharma Holdings Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 19, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 112,677 | 180,683 | 236,407 | 245,618 | 325,444 | 260,969 | Upgrade
|
| Market Cap Growth | -11.89% | -23.57% | -3.75% | -24.53% | 24.71% | -34.11% | Upgrade
|
| Enterprise Value | 320,774 | 429,021 | 424,544 | 404,795 | 543,483 | 410,501 | Upgrade
|
| Last Close Price | 7340.00 | 11694.36 | 15235.70 | 15769.33 | 20811.81 | 16631.87 | Upgrade
|
| PE Ratio | - | - | - | - | 28.47 | - | Upgrade
|
| PS Ratio | 0.14 | 0.22 | 0.30 | 0.32 | 0.43 | 0.36 | Upgrade
|
| PB Ratio | 0.34 | 0.45 | 0.56 | 0.49 | 0.65 | 0.54 | Upgrade
|
| P/TBV Ratio | 0.49 | 0.67 | 0.91 | 0.96 | 1.39 | 1.19 | Upgrade
|
| P/FCF Ratio | 10.22 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 8.68 | - | - | 18.33 | - | 10.35 | Upgrade
|
| EV/Sales Ratio | 0.41 | 0.53 | 0.54 | 0.53 | 0.71 | 0.56 | Upgrade
|
| EV/EBITDA Ratio | - | 12.82 | 126.46 | 48721.60 | 17.73 | 24.84 | Upgrade
|
| EV/EBIT Ratio | - | 20.51 | - | - | 24.70 | 44.96 | Upgrade
|
| EV/FCF Ratio | 29.10 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.35 | 0.53 | 0.39 | 0.23 | 0.30 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | - | 6.40 | 48.44 | 13850.20 | 4.89 | 7.42 | Upgrade
|
| Debt / FCF Ratio | 13.91 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.86 | 0.92 | 0.90 | 0.86 | 0.88 | 0.83 | Upgrade
|
| Inventory Turnover | 4.20 | 4.94 | 5.38 | 4.88 | 5.17 | 5.65 | Upgrade
|
| Quick Ratio | 0.65 | 0.61 | 0.65 | 0.71 | 0.63 | 0.67 | Upgrade
|
| Current Ratio | 1.01 | 0.93 | 0.98 | 1.12 | 1.02 | 1.00 | Upgrade
|
| Return on Equity (ROE) | -14.47% | -3.22% | -18.07% | -2.58% | 3.05% | -17.83% | Upgrade
|
| Return on Assets (ROA) | -0.98% | 1.50% | -0.54% | -0.63% | 1.59% | 0.65% | Upgrade
|
| Return on Capital (ROIC) | -1.42% | 2.18% | -0.79% | -0.89% | 2.19% | 0.87% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 4.48% | - | - | 3.93% | 1.72% | Upgrade
|
| Earnings Yield | -36.81% | -8.99% | -31.54% | -1.42% | 3.51% | -34.68% | Upgrade
|
| FCF Yield | 9.78% | -5.89% | -13.84% | -4.19% | -10.29% | -4.78% | Upgrade
|
| Dividend Yield | 0.68% | 0.43% | 0.33% | 0.41% | 0.34% | 0.42% | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | 13.88% | - | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | -195.86% | Upgrade
| |
| Total Shareholder Return | 0.68% | 0.43% | 0.33% | 0.41% | 0.34% | -195.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.